PAPA JOSEPH C
SEC CIK 1242215 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | Pres, CEO, Dir | 493.2K | $349.8K | — | 4 | 2025-03-06 | 2026-04-29 |
| MIST | Milestone Pharmaceuticals Inc. | Dir | 100.0K | — | — | 1 | 2025-07-11 | 2025-07-11 |
| CADL | Candel Therapeutics, Inc. | Dir | 64.2K | $73.1K | — | 2 | 2022-12-08 | 2025-06-25 |
| BHC | Bausch Health Companies Inc. | Dir | 1.43M | — | — | 6 | 2021-09-13 | 2022-05-10 |
| BLCO | Bausch & Lomb Corp | CEO, COB, Dir | 472.2K | — | — | 1 | 2022-05-05 | 2022-05-05 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
| 14 | PAPA JOSEPH C | Pres, CEO, Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 16:26 | 2026-04-29 | EBS | Emergent BioSolutions Inc. | PAPA JOSEPH C | Pres, CEO, Dir | A - Grant | $0.00 | +187.7K | 493.2K | +61% | $0 | |
| D | 2026-03-05 | 2026-03-05 | EBS | Emergent BioSolutions Inc. | PAPA JOSEPH C | Pres, CEO, Dir | F - Tax | $8.44 | -37.1K | 305.4K | -11% | -$312.7K |
| D | 2025-07-15 | 2025-07-11 | MIST | Milestone Pharmaceuticals Inc. | PAPA JOSEPH C | Dir | A - Grant | — | +100.0K | 100.0K | New | — |
| I | 2025-06-26 | 2025-06-25 | CADL | Candel Therapeutics, Inc. | PAPA JOSEPH C | Dir | A - Grant | $4.67 | +64.2K | 64.2K | New | +$300.0K |
| 2025-05-15 | 2025-05-13 | EBS | Emergent BioSolutions Inc. | PAPA JOSEPH C | Pres, CEO, Dir | P - Purchase | $5.83 | +60.0K | 342.5K | +21% | +$349.8K | |
| D | 2025-03-10 | 2025-03-06 | EBS | Emergent BioSolutions Inc. | PAPA JOSEPH C | Pres, CEO, Dir | A - Grant | $0.00 | +282.5K | 282.5K | New | $0 |
| M | 2022-12-12 | 2022-12-08+ | CADL | Candel Therapeutics, Inc. | PAPA JOSEPH C | Dir | P - Purchase | $1.92 | +38.0K | 3,014 | New | +$73.1K |
| D | 2022-05-12 | 2022-05-10 | BHC | Bausch Health Companies Inc. | PAPA JOSEPH C | Dir | F - Tax | $9.40 | -33.7K | 1.43M | -2% | -$316.9K |
| DM | 2022-05-12 | 2022-05-10 | BHC | Bausch Health Companies Inc. | PAPA JOSEPH C | Dir | M - OptEx | — | +366.1K | 1.21M | +43% | — |
| D | 2022-05-09 | 2022-05-05 | BLCO | Bausch & Lomb Corp | PAPA JOSEPH C | CEO, COB, Dir | A - Grant | $0.00 | +472.2K | 472.2K | New | $0 |
| 2022-03-07 | 2022-03-03 | BHC | Bausch Health Companies Inc. | PAPA JOSEPH C | COB, CEO, Dir | F - Tax | $23.61 | -12.6K | 1.10M | -1% | -$298.5K | |
| D | 2022-03-02 | 2022-02-27 | BHC | Bausch Health Companies Inc. | PAPA JOSEPH C | COB, CEO, Dir | M - OptEx | — | +208.2K | 1.24M | +20% | — |
| DM | 2022-03-02 | 2022-02-26+ | BHC | Bausch Health Companies Inc. | PAPA JOSEPH C | COB, CEO, Dir | F - Tax | $24.34 | -131.9K | 1.11M | -11% | -$3.21M |
| M | 2021-09-15 | 2021-09-13+ | BHC | Bausch Health Companies Inc. | PAPA JOSEPH C | COB, CEO, Dir | F - Tax | $28.88 | -8,559 | 1.04M | -0.8% | -$247.2K |
Purchase Sale Sale after option exercise All abbreviations